BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6862153)

  • 1. Portal vein ligation selectively lowers hepatic cytochrome P450 levels in rats.
    Farrell GC; Zaluzny L
    Gastroenterology; 1983 Aug; 85(2):275-82. PubMed ID: 6862153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hepatic ischemia-reperfusion injury on the hepatic mixed function oxidase system in rats.
    Lindstrom TD; Hanssen BR; Bendele AM
    Mol Pharmacol; 1990 Dec; 38(6):829-35. PubMed ID: 2250663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-function oxidase system induction and propylene hepatotoxicity.
    Osimitz TG; Conolly RB
    J Toxicol Environ Health; 1985; 15(1):39-49. PubMed ID: 2984438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of portacaval transposition on hepatic cytochrome P-450 in the rat.
    Pector JC; Ossenberg FW; Peignoux M; Benhamou JP
    Biomedicine; 1975 Jun; 23(5):160-2. PubMed ID: 1191728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of portal vein ligation on sex hormone metabolism in male rats: relationship to lowered hepatic cytochrome P450 levels.
    Farrell GC; Koltai A; Zaluzny L; Murray M
    Gastroenterology; 1986 Feb; 90(2):299-305. PubMed ID: 3940910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of mixed-function oxidases and purified cytochrome P-450 of livers of house musk shrew, Suncus murinus.
    Mizokami K; Fukuhara M; Nohmi T; Sunouchi M; Fujimori K; Takanaka A; Omori Y
    Drug Metab Dispos; 1988; 16(1):151-5. PubMed ID: 2894946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aluminum on the hepatic mixed function oxidase and drug metabolism.
    Bidlack WR; Brown RC; Meskin MS; Lee TC; Klein GL
    Drug Nutr Interact; 1987; 5(1):33-42. PubMed ID: 3105994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of repeated administration of monomethyl-aminoantipyrine on the activities of gamma-glutamyltranspeptidase and microsomal drug metabolizing enzymes in rat liver.
    Hoshi K; Senda N; Igarashi T; Satoh T; Ueno K; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):431-43. PubMed ID: 2862671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemin administration to rats reduces levels of hepatic mRNAs for phenobarbitone-inducible enzymes.
    Srivastava G; Hansen AJ; Bawden MJ; May BK
    Mol Pharmacol; 1990 Oct; 38(4):486-93. PubMed ID: 2233690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic mixed function oxidase system and enzymatic glucose metabolism in rats.
    Karvonen I; Stengård JH; Saarni HU; Stenbäck F; Sotaniemi EA
    Diabetes Res; 1987 Apr; 4(4):195-200. PubMed ID: 3040322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired expression of microsomal cytochrome P450 2C11 in choline-deficient rat liver during the development of cirrhosis.
    Murray M; Cantrill E; Mehta I; Farrell GC
    J Pharmacol Exp Ther; 1992 Apr; 261(1):373-80. PubMed ID: 1560381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic cytochrome P-450 and in vitro drug metabolism in an overfed rat model of obesity.
    Matsumoto RM; Jusko WJ; Corcoran GB
    Drug Nutr Interact; 1988; 5(4):236-47. PubMed ID: 3149237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of the male-specific hepatic microsomal steroid 16 alpha-hydroxylase, cytochrome P-450UT-A, in rats with portal bypass. Relevance to estradiol accumulation and impaired drug metabolism in hepatic cirrhosis.
    Cantrill E; Murray M; Mehta I; Farrell GC
    J Clin Invest; 1989 Apr; 83(4):1211-6. PubMed ID: 2703529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent toxicity of acorn extract in young and old male rats.
    Govindwar SP; Dalvi RR
    Vet Hum Toxicol; 1990 Feb; 32(1):23-6. PubMed ID: 2301145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-(8-Methoxy-4,8-dimethylnonyl)-4-(1-methyl-ethyl)benzene (MV-678): a reversible inducer of rat hepatic microsomal drug metabolism.
    Clement RP; Zwicker GM; Chin TY; Freudenthal RI
    J Toxicol Environ Health; 1986; 19(1):111-25. PubMed ID: 3746938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of age on the activity of hepatic mixed function oxidases in female rats after phenobarbital induction].
    Plewka D; Plewka A; Kamiński M
    Med Pr; 1988; 39(6):381-90. PubMed ID: 3252102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of spices and spice principles on hepatic mixed function oxygenase system in rats.
    Sambaiah K; Srinivasan K
    Indian J Biochem Biophys; 1989 Aug; 26(4):254-8. PubMed ID: 2628260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus.
    Karvonen I; Stengård JH; Huupponen R; Stenbäck FG; Sotaniemi EA
    Diabetes Res; 1989 Feb; 10(2):85-92. PubMed ID: 2501061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of portal arterialization on hepatic cytochrome P-450 in rats with portacaval shunt.
    Pector JC; Verbeustel S; Lambilliotte JP
    Digestion; 1975; 12(3):144-51. PubMed ID: 1183748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of perfluorodecanoic acid on hepatic stearoyl-coenzyme A desaturase and mixed function oxidase activities in rats.
    Van Rafelghem MJ; Andersen ME
    Fundam Appl Toxicol; 1988 Oct; 11(3):503-10. PubMed ID: 2906022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.